Ominous sign for Korean drugmakers

Along with the government’s strong will to cut the prices of drugs in question by 20 percent if their producers are found to offer rebates to doctors and pharmacists, domestic companies have again been subject to a difficult situation, according to market experts.

They pointed out that although undue rebates and kickbacks should be stamped out, these old illegalities should not be linked to...